Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the ...

Expanded Ozempic approval in the U.S. could transform how doctors treat patients with chronic kidney disease, which involves ...

People with chronic kidney disease may not experience any skin symptoms ... Unless another underlying cause is present, healthcare professionals may consider any itchy skin in a person with ...

Body-weight cycling, sometimes referred to as yo-yo dieting, may be harmful to the kidneys for people with type 1 diabetes, ...

A team led by Dr. Erik Larson, vice chair of the Department of Biomedical Sciences, has uncovered the cause of a common kidney disease after eight years of research, a news release from WMed said.

Dialysis Centers used data from the Centers for Disease Control and Prevention to examine the prevalence of chronic diseases ...

Minister of Health Dr. Ahmad Al-Awadhi stated that diabetes is one of the most prevalent and significant chronic diseases in ...

has officially approved Ozempic to help reduce the risk of serious kidney complications in people with type 2 diabetes and ...

Due to severe water pollution, many people in Paralachi, Rajagopalapuram, Thoppalakarai, Thummuchinnampatti and other habitations in Virudhunagar district suffer from chronic kidney diseases (CKD ...

Heart disease remains the leading cause of death in the U.S.

Ozempic becomes the first GLP-1 treatment option for people with type 2 diabetes and chronic kidney disease Mario Tama/Getty The Food and Drug Administration has approved Ozempic to reduce the ...